Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
Seminars in Cancer Biology|October 24, 2006
On the potential of thioredoxin reductase inhibitors for cancer therapySabine Urig, Katja BeckerMedicinal Research Reviews|November 5, 2003
The thioredoxin system--from science to clinicStephan Gromer, Sabine Urig, Katja BeckerJournal of Molecular Biology|May 22, 2007
The structure of human thioredoxin reductase 1 provides insights into C-terminal rearrangements during catalysisKarin Fritz-Wolf, Sabine Urig, Katja BeckerFEBS Letters|June 6, 2006
Truncated mutants of human thioredoxin reductase 1 do not exhibit glutathione reductase activitySabine Urig, Johanna Lieske, Karin Fritz-Wolf, et al.Journal of Molecular Biology|June 25, 2002
The Escherichia coli dam DNA methyltransferase modifies DNA in a highly processive reactionSabine Urig, Humaira Gowher, Andrea Hermann, et al.Free Radical Biology & Medicine|May 15, 2009
Differential genomic and proteomic profiling of glioblastoma cells exposed to terpyridineplatinum(II) complexesSasa Koncarevic, Sabine Urig, Klaus Steiner, et al.Biological Chemistry|October 17, 2007
Glutathione- and thioredoxin-related enzymes are modulated by sulfur-containing chemopreventive agentsYing Hu, Sabine Urig, Sasa Koncarevic, et al.Journal of Medicinal Chemistry|October 28, 2005
Synthesis of 5-nitro-2-furancarbohydrazides and their cis-diamminedichloroplatinum complexes as bitopic and irreversible human thioredoxin reductase inhibitorsRégis Millet, Sabine Urig, Judit Jacob, et al.Free Radical Biology & Medicine|March 8, 2006
Antiglioma activity of 2,2':6',2"-terpyridineplatinum(II) complexes in a rat model--effects on cellular redox metabolismRezvan Ahmadi, Sabine Urig, Marius Hartmann, et al.The Journal of Biological Chemistry|March 29, 2005
Mechanistic studies on a novel, highly potent gold-phosphole inhibitor of human glutathione reductaseMarcel Deponte, Sabine Urig, L David Arscott, et al.Pageof 1